Children exposed to antiretroviral (ARV) therapy in utero and not exposed to HIV showed no difference in language development ...
After 96 weeks, 4% taking TAF/emtricitabine and 16% taking TDF/emtricitabine had a 5% or greater drop in spine bone mass density. Two people out of 2694 people taking TAF/emtricitabine stopped ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback